Breaking News, Collaborations & Alliances

IDT Biologika, NIH Mfg. Contract Updated

Awarded new task order in the scope of 10-year NIH contract to manufacture vaccines and biologics for infectious diseases.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

IDT Biologika, a globally integrated manufacturer of vaccines and biopharmaceuticals, said that the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH), an agency of the United States Department of Health and Human Services, has awarded the company a new Task Order within the 10-year Indefinite Delivery, Indefinite Quantity (IDIQ) contract no. HHSN272201800011I to provide process development activities and production of a vaccine against the R...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters